Table 1. Treatment outcomes in clear cell renal cell carcinoma patients presenting with synchronous metastasis in other organs as well as bladder metastasis
Author | Year | Source of reference | Periods from nephrectomy (months) | Simultaneous additional metastasis | Therapy | Period from diagnosis of bladder metastasis (months) | Prognosis |
|---|---|---|---|---|---|---|---|
Takahashi E | 2001 | [Article in Japanese] Rinsho Hinyokika | 5 | Bone | N.A. | 7 | Death from cancer |
Kamota S | 2003 | [Article in Japanese] Nihon Hinyokika Gakkai Zasshi | 4 | Lung and ureter | – | 22 | Death from cancer |
Kume H | 2007 | [Article in Japanese] Nihon Hinyokika Gakkai Zasshi | 204 | Bone | – | 19 | Death from another cause |
Kume H | 2007 | [Article in Japanese] Nihon Hinyokika Gakkai Zasshi | 48 | Lung and liver | – | 14 | Death from cancer |
Wang K | 2015 | Oncol Lett | 60 | Adrenal gland | Targeted | 12 | Alive with cancer |
Li H | 2016 | Oncol Lett | 1 | Renal bed | – | 0.5 | Death from cancer |
Groote RD | 2018 | Ther Adv Urol | 60 | Liver | Targeted | 57 | Alive with no cancer |
Babar M | 2019 | BMC Urol | 336 | Lung, bone, thyroid, and inferior vena cava | Targeted→ICI | 25 | Alive with cancer |
Present case | 2022 | Herein | 48 | Lung, bone, renal bed | ICI | 15 | Alive with cancer |